Her2 Amplification is Significantly More Frequent in Lymph Node Metastases From Urothelial Bladder Cancer Than in the Primary Tumours (Q54585164)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 25, 2011

edit

Language	Label	Description	Also known as
English	Her2 Amplification is Significantly More Frequent in Lymph Node Metastases From Urothelial Bladder Cancer Than in the Primary Tumours	scientific article published on May 25, 2011

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21640482

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21640482

title

Her2 Amplification is Significantly More Frequent in Lymph Node Metastases From Urothelial Bladder Cancer Than in the Primary Tumours (English)

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

main subject

lymph node

0 references

bladder cancer

1 reference

based on heuristic

inferred from title

author

Roland Seiler

series ordinal

3

object named as

Roland Seiler

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21640482

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21640482

retrieved

3 December 2024

author name string

Achim Fleischmann

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21640482

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21640482

Diana Rotzer

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21640482

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21640482

Urs E. Studer

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21640482

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21640482

retrieved

3 December 2024

George N. Thalmann

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21640482

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21640482

retrieved

3 December 2024

language of work or name

English

0 references

publication date

25 May 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21640482

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21640482

full work available at URL

https://api.elsevier.com/content/article/PII:S0302283811005240?httpAccept=text/plain

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

https://api.elsevier.com/content/article/PII:S0302283811005240?httpAccept=text/xml

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

published in

European Urology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21640482

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21640482

volume

60

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21640482

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21640482

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21640482

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21640482

page(s)

350-357

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21640482

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21640482

cites work

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

series ordinal

1

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

series ordinal

2

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

Trastuzumab--mechanism of action and use in clinical practice

series ordinal

3

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients.

series ordinal

5

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?

series ordinal

6

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

Potential for HER-2/neu molecular targeted therapy for invasive bladder carcinoma: comparative study of immunohistochemistry and fluorescent in situ hybridization

series ordinal

7

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

HER-2 and TOP2A coamplification in urinary bladder cancer

series ordinal

8

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis

series ordinal

9

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor

series ordinal

10

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

series ordinal

11

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

Systemic chemotherapy for advanced bladder cancer: update and controversies

series ordinal

12

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

Role of anti-Her-2 therapy in bladder carcinoma

series ordinal

13

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

Experience in 100 patients with an ileal low pressure bladder substitute combined with an afferent tubular isoperistaltic segment.

series ordinal

14

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

Tissue microarrays for high-throughput molecular profiling of tumor specimens

series ordinal

16

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

Change of HER-2/neu status in a subset of distant metastases from breast carcinomas

series ordinal

17

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

HER2 overexpression and amplification in urothelial carcinoma of the bladder is associated with MYC coamplification in a subset of cases

series ordinal

18

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

Her-2/neu overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic significance and comparative analysis in primary and metastatic tumors

series ordinal

19

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations

series ordinal

20

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

HER-2 testing in breast cancer using parallel tissue-based methods

series ordinal

21

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes

series ordinal

22

1 reference

stated in

Crossref

DOI

10.1016/J.EURURO.2011.05.035

reference URL

https://api.crossref.org/works/10.1016/J.EURURO.2011.05.035

retrieved

3 December 2024

Identifiers

DOI

10.1016/J.EURURO.2011.05.035

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21640482

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21640482

PubMed publication ID

21640482

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21640482

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/21640482

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54585164&oldid=2283183725"